Newsletter

Pompe Disease
With one marketed therapy, and several in pipeline, Pompe disease market is anticipated to boost in the coming decade
Pompe Disease Newsletter

More Whitepapers / Newsletters

Alzheimer's disease
Alzheimer's disease

Alzheimer's disease is an irreversible, progressive disorder of the brain that progressively destroys memory and thinking skills of an individual. It is the most common cause of dementia (a continuous...

HIV-Associated Lipodystrophy Market
HIV-Associated Lipodystrophy

HIV-associated lipodystrophy (HAL), is a condition characterized by the redistribution of adipose tissue. It can be due to several reasons, however, a significant amount of research done links its cau...

Microneedles Whitepaper
Microneedles: A Smart and Pain...

A formal medical disorder affecting approximately 10 percent of the world population is trypanophobia, or the fear of needles. Nonetheless, transcutaneous or transdermal injections and intravenous inj...

Chronic Pancreatitis
Chronic Pancreatitis

Chronic Pancreatitis is an inflammation of the pancreas that can be a result of calcium stones and cysts, acute inflammation, cystic fibrosis, unhealthy lifestyle habits, certain autoimmune disorders...

Current Treatment Challenges Of IO Refractory Patients And Clinical Development Of Therapies Targeting These Patients
Current Treatment Challenges O...

Over the years, the Oncology domain has experienced the entry of several treatment approaches. Therapeutic approaches such as surgery, radiation therapy, and chemotherapy form the conventional methods...